NEA PARTNERS 10 L P
CIK 1236049 · last filed 2020-08-18
NEA PARTNERS 10 L P is a corporate insider who has filed 13 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for BE, was dated Aug 18, 2020. Across all open-market trades the lifetime net is −$5.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $187.0M across reported positions. The firm reports its address in Baltimore, MD. 57 SEC filings were submitted jointly with Enterprise Associates 10 L P New.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WIFI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BALTIMORE, MD 21202
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BE | 10%+ Owner | — | $215.54 | — | $0 | 1 | 2020-08-18 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 50,012 | $15.70 | $785.2K | -$346.0K | 2 | 2018-05-11 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | 10%+ Owner | 1,794,814 | — | — | $0 | 1 | 2015-07-02 |
| BOINGO WIRELESS, INC. (WIFI) Delisted | 10%+ Owner | 8,264,279 | $13.99 | $115.62M | -$5.00M | 3 | 2014-12-15 |
| VG | 10%+ Owner | 14,131,890 | $12.64 | $178.70M | $0 | 2 | 2011-03-15 |
| Data Domain, Inc. (DDUP) Delisted | 10%+ Owner | 8,669,129 | — | — | $0 | 1 | 2008-11-26 |
| TNDM | 10%+ Owner | 485,220 | $17.18 | $8.34M | $0 | 1 | 2008-08-20 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-18 | BE | Conv (C) | — | $0 | EDGAR |
| 2018-05-11 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Mixed | +1,009,826 | -$241 | EDGAR |
| 2015-11-18 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Mixed | +17,986 | -$13 | EDGAR |
| 2015-07-02 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Other (J) | −825,000 | $0 | EDGAR |
| 2014-12-15 | BOINGO WIRELESS, INC. (WIFI) Delisted | Sell (S) | −632,305 | -$5.00M | EDGAR |
| 2013-12-12 | BOINGO WIRELESS, INC. (WIFI) Delisted | Other (J) | −1,000,000 | $0 | EDGAR |
| 2013-08-23 | BOINGO WIRELESS, INC. (WIFI) Delisted | Other (J) | −965,000 | $0 | EDGAR |
| 2011-03-15 | VG | Other (J) | −6,960,481 | $0 | EDGAR |
| 2009-02-03 | — | — | — | $0 | |
| 2008-11-26 | Data Domain, Inc. (DDUP) Delisted | Other (J) | −7,073,584 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.